检索

标题
作者
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
Monogennye formy sakharnogo diabeta
Zubkova N., Tikhonovich Y., Tyul'pakov A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy
Druk I., Safronova S., Kulebakina K.
Possibilities of using insulin degludec in the treatment of diabetes mellitus in patients with previous ineffective insulin therapy: analysis of clinical cases
Elsukova O.
Vaccination against pneumococcal infection in patients with diabetes mellitus
Tarasova A., Kostinov M., Novopoltseva E.
Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice
Elsukova O., Nikitina E.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.
Diabetes mellitus and new coronavirus infection: a look into the past; conclusions on prevention and treatment tactics for the future
Aramisova L., Zhurtova I., Gubachikova A.
Metabolic comorbidity of endometritis after caesarean section
Korobkov N., Bakulina N., Borovik N.
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
Application of the diabetes screening questionnaire in patients with psoriasis
Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
Smirnova E.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
Cranial neuropathy as a complication of diabetes mellitus
Maksimova M., Stepanchenko O.
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A., Sharonova L., Burakshayev S., Kotelnikova E., Smirnova T.
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
Gusenbekova D., Ametov A., Butaeva S.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.
Kombinirovannaya terapiya bolevoy diabeticheskoy polineyropatii: rezul'taty pilotnogo issledovaniya
Khramilin V., Andreeva V., Demidova I.
SAKhARNYY DIABET: OT PONIMANIYa ETIOLOGII K VYBORU LEChENIYa
Kononenko I., Smirnova O.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V., Nichitenko M., Chesnikova A.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)
Legun A., Vetsheva M.
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Adherence to modern technologies of glycemic management in diabetic patients
Chernikova N., Prokhorova K., Gancho I.
Diabetes mellitus and periodontal diseases: together or in parallel?
Trukhan D., Sulimov A., Trukhan L.
Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study
Safronova S., Druk I., Kanunnikova O., Korennova O., Podolnaya S., Klepatskaya T., Kalinina I.
Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases
Smirnova E.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
Zhurtova I., Aramisova L., Abdul Moati H., Arkhestova D., Khachmakhova E.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
Glucometer with a mobile application as a system for remote control of diabetes
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I., Demina A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M., Gurova O., Fadeev V.
Statins and the risk of diabetes: an evidence-based review
Leonova M.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
Features of urine microflora in diabetic patients
Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
Biryukova E.
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM
Martynov A., Akatova E., Nikolin O., Urlaeva I.
Opyt primeneniya Aktovegina v lechenii neyroishemicheskoy formy sindroma «diabeticheskaya stopa»
Dibirov M., Gadzhimuradov R., Khalidov O., Proshin A., Kakubava M.
Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod
Zanozina O., Sorokina Y., Lovtsova L., Borovkov N.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M., Koteshkova O.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I., Svetlova O.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E., pl?midmagidsid Y.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.
Common bean (Phaseolus vulgaris L.)/
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.
New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus
Den'gin V., Dengin V.
Diabetic foot syndrome: approaches to treatment of infection
Privol'nev V., Privolnev V.
Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery
Mozgunova V., Volkova A., Semikova G., Khalimov Y., Vasilevsky D., Balandov S., Anisimova K.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
Kurnikova I., Chekalina M., Ualikhanova A.
1 - 100 的 369 信息 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语